The nation of Zimbabwe has rejected a significant US health deal valued at $367m (£272m) over five years because of Washington's demand for confidential information.
The decision was revealed after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government representative later explained that the US was seeking health data for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further talks to find a deal agreeable to all parties so the country's vital HIV programme can proceed.
Broader Context
This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
As per reports, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information indefinitely, without any corresponding assurance of access to any medical innovations – like new medicines or tests – that might result from that provided information," he stated.
"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the end products would be accessible to our citizens if a future disease outbreak emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting frameworks already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to ongoing dialogue with our American counterparts on how future collaboration might be designed in a way that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body said it acknowledged the government's concerns, but recommended that talks must proceed considering much of the nation's HIV programmes depended on foreign aid.
"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it commented.
The situation underscores the ongoing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.